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Introduction
Papillophlebitis is an uncommon ocular condition of 
undetermined etiology. Unlike classic central retinal vein 
occlusion, patients suffering from this disease are usually healthy 
and younger than 50 years of age.1,2 Most patients complain 
of blurred vision and photopsia. Typical findings include 
dilatation and tortuosity of the major retinal veins with retinal 
hemorrhage and optic disc edema.2 Traditional treatment for 
papillophlebitis includes systemic and periocular steroid therapy, 
intravitreal triamcinolone, intravitreal anti-VEGF inhibitors, 
platelet inhibitors, and anticoagulation.3,4,5 Guillain-Barré 
syndrome (GBS) is an immune-mediated acute polyneuropathy 
principally affecting motor nerves and causing paralysis.6 It is 
the most common cause of acute muscle weakness associated 
with peripheral neuropathy in adults and can be lethal if not 
treated early.7 GBS is reported to be associated with Zika virus 
infection.8 There are a few case presentations in the literature 
reporting total ophthalmoplegia, optic nerve involvement, 
ptosis, Vogt-Koyanagi-Harada, and uveitis as ocular findings of 
GBS.9,10,11,12
Here we report a case with visual deterioration in the right 
eye with numbness, pain, and tingling sensation in both lower 
legs.
Case Report
A 53-year-old woman presented with complaints of visual 
deterioration in the right eye. Her anamnesis revealed no 
ocular or systemic diseases except a mild influenza-like illness 
a week earlier. Her best corrected visual acuity (BCVA) was 
0.5 in the right and 1.0 in the left eye. Anterior segment 
examination and intraocular pressure was within normal range 
in both eyes. Fundoscopic examination of the right eye revealed 
splinter hemorrhages, optic nerve head hemorrhage, and cotton 
wool spots in the superior arcuate region, and the patient was 
diagnosed with papillophlebitis (Figure 1). Fundus fluorescein 
angiography revealed no ischemic areas; however, there was 
hypofluorescence in the areas corresponding to hemorrhages, 
and hyperfluorescence in the optic nerve head (Figure 2). 
Optical coherence tomography revealed macular edema and 
intraretinal edema and hyperreflective spots in the nasal fovea 
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corresponding to the areas affected by the occlusion (Figure 3). 
Laboratory and radiological tests were requested to determine 
the etiology of the papillophlebitis. One week after onset of these 
complaints, the patient began to experience numbness, pain, and 
tingling sensation in both lower legs. Motor weakness became 
progressively severe in both extremities and she was admitted 
to the neurology clinic for advanced examination and treatment. 
No abnormalities were detected in magnetic resonance imaging 
of the brain and spinal cord. Complete blood count, electrolytes 
and blood chemistry and urinalysis were normal. Coagulation 
tests, including serum levels of homocysteine, protein C and 
S, partial thromboplastin time, and prothrombin time were 
normal. Erythrocyte sedimentation rate and anticardiolipin G 
and M were within normal range. Lumbar puncture revealed 
no pathology. She was diagnosed with GBS and treated with 
intravenous immunoglobulin (IVIg) therapy. Her symptoms 
improved in the following 3 months. During follow-up, her 
BCVA in the right eye returned to 1.0 without any treatment for 
ocular findings (Figure 4). 
Discussion
GBS is usually preceded by infection or other immune 
stimulation that induces an aberrant autoimmune response 
targeting the peripheral nerves and their spinal roots.13,14 
Two-thirds of adult patients report preceding symptoms of a 
respiratory or gastrointestinal tract infection within 4 weeks 
of onset.15 Underlying systemic diseases such as systemic lupus 
erythematosus (SLE), sarcoidosis, Hodgkin disease, and other 
neoplasms have been known to cause a small number of GBS 
cases.16 
The pathogenesis of GBS as a manifestation of active SLE 
is not clear, but both cell-mediated and humoral processes 
may play a significant role.17 Ocular findings in SLE include 
hemorrhage, retinal cotton wool spots, microangiopathy, and 
vaso-occlusion as a result of immune complex deposition. The 
role of immune complex deposition is highlighted in vascular 
pathogenesis in the eye.15
Our patient was relatively young and did not suffer from 
any systemic diseases. Her anamnesis revealed only an influenza-
like illness with mild symptoms the week before. To the best 
of our knowledge, there are no previous reports in the literature 
of papillophlebitis as the initial presentation of GBS. Although 
the two clinical presentations may be coincidental, it may be 
postulated that papillophlebitis in our patient was related to the 
immune-mediated etiology of GBS, as is seen in SLE.
Figure 1. Fundoscopic examination revealed splinter hemorrhages, optic nerve 
head hemorrhage, and cotton wool spots due to ischemia in the superior arcuate 
region and a diagnosis of papillophlebitis was made
Figure 3. Optical coherence tomography revealed macular edema and intraretinal 
edema and hyperreflective spots in the nasal fovea corresponding to the areas 
affected by the occlusion
Figure 4. During follow-up, the patient’s best corrected visual acuity in the right 
eye returned to 1.0 without any treatment for ocular findings. Hemorrhages and 
cotton wool spots improved without any specific ocular treatment
Figure 2. Fundus fluorescein angiography revealed no ischemic areas; however, 
there was hypofluorescence in the areas corresponding to hemorrhages and 
hyperfluorescence in the optic nerve head
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In conclusion, we present this case in order to emphasize 
the importance of etiologic diagnosis in papillophlebitis. 
Papillophlebitis may be an initial finding of GBS, which may 
lead to serious neurologic complications if not treated early. 
Treatment modalities may differ with the etiologic diagnosis. 
Early initiation of IVIg or plasma exchange is of proven benefit 
and crucial in GBS.19 In our patient, no specific treatment for 
ocular findings was applied, as the papillophlebitis resolved with 
systemic treatment of GBS without leaving any sequelae. This 
may also be the result of the benign course of the papillophlebitis 
and the reversal of the findings of papillophlebitis may be the 
natural outcome.
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